Expanding Access to Preventive Chemotherapy Among Mobile and Migrant Populations

NCT07707817 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

5760

Enrollment

OTHER

Sponsor class

Conditions

Onchocerciasis (River Blindness)
Schistosomiasis
Soil Transmitted Helminth (STH) Infections
Lymphatic Filariasis

Interventions

OTHER: Modified Mass Administration of Medicines Strategy
DRUG: Albendazole 400 mg
DRUG: Praziquantel 40 mg/kg
DRUG: Ivermectin
DRUG: Ivermectin + albendazole

Sponsor

Uwemedimo Friday Ekpo

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]